Signal Transduction Inhibitors in Cellular Function
互联网
Signal Transduction Pathways |
Inhibitors |
References |
---|---|---|
Tyrosine Kinase Growth Factor Receptors |
||
HER2/Neu inhibitor |
Herceptin (anti-HER2 antibody) |
(53,54) |
EGF receptors |
IMC-C225 (anti-EGFR antidody) |
(55,56) |
EGFR-Tyrosine kinase |
ZD1839, pyridopyrimidines |
(54,57,58) |
Ras Signaling |
||
Inhibitors of Ras farnesyltransferase FPP analogues |
||
CAAX peptide analogues |
BZA-5B, L-739, Cys-4-ABA-Met FT1-276, SCH44342, SCH66336 |
(57 –59) |
Bisubstrate inhibitors |
BMS-182878, BMS-184467 |
(57 –59) |
Inhibitors of the Raf protein kinases |
ISIS5132, BAY43-9006 |
(57 –59) |
Mitogen-Activated Protein Kinase Pathways |
||
Inhibitors of MEK |
PD184352, PD098059, U0126, R009-22110 |
(17,20,21 , 23 –27) |
Inhibitors of ERK1 and ERK2 |
PD098059, E64D, calpeptin |
(5,28) |
Inhibitors of JNKs |
SB600125 |
(33,34) |
Inhibitors of p38 kinases |
SB203580, SB202190, SB242235, SB239063, SB220025, SB202474, SC68376, FR167653 |
(36,37 , 39 –44,46) |
Inhibitors of PI3-Kinase Signaling Pathways |
Wortmannin, LY294002 |
(60,61) |
Protein Phosphatases Inhibitors Proteasome Inhibitors |
Microcystines, calyculins, cantharidin |
(67) |
Peptide aldehydes |
ALLN, MG132, PSI, MG115 |
(63) |
Peptide boronates |
MG262 |
(63) |
Nonpeptide inhibitors |
Lactacystin |
(63) |
DCI |
3,4-DCI |
(63,64) |
Peptide vinyl sulfones |
NLVS, YL3YS |
(63) |
Epoxyketones |
Epoxomicin, eponemycin, Ac-hFLFL-epoxide |
(63,65) |
Bivalent inhibitors |
Polyoxyethylene |
(66,67) |
Natural compound inhibitors |
TMC-95A, gliotoxin, EGCG |
(63,68) |
Histone Deacetylase inhibitors |
||
Short-chain fatty acids |
Butyrates |
(70,75) |
Hydroxamic acids |
Trichostatin A, oxamflatin |
(73) |
Cyclic peptides |
Trapoxin A, FR901228, apicidin |
|
Benzamides |
MS-27275 |
(78,80) |
SIR2 inhibitors |
Nicotinamide, splitomicin |
(78,79) |